Virginia declares an opioid public health emergency and issues a standing naloxone order

Virginia’s late-2016 declaration of an opioid public health emergency paired official recognition of the crisis with a practical measure: a standing order allowing any resident to obtain naloxone, the overdose-reversing drug. It widened access to a means of preventing deaths, but unfolded amid deeper failures in insurance coverage and addiction treatment that the order alone could not resolve.

Causes and Background

By late 2016, Virginia State Health Commissioner Marissa J. Levine reported that three Virginians were dying every day from drug overdoses and that emergency departments statewide were seeing more than two dozen overdose cases daily. The declaration made the scale of the crisis a matter of public policy; its companion standing order authorized residents to buy naloxone without obtaining an individual prescription.

The emergency had roots beyond the immediate danger of overdose. In rural Virginia, globalization, automation, and the decline of coal accompanied rising crime, food insecurity, and disability claims. In Martinsville and surrounding Henry County, unemployment exceeded 20 percent, food stamp claims more than tripled, and disability rates increased by 60.4 percent. Researcher Shannon Monnat described the wider crisis as the convergence of collapsing work and expanding painkiller supply, with economic distress acting as kindling and opiates as the spark. This account placed the emergency declaration against conditions that shaped both exposure to addiction and people’s prospects for recovery.

The medical and commercial history of opioid prescribing formed another part of that background. Purdue Pharma promoted OxyContin as safe for a wide range of pain, repeating a claim that addiction rates were below 1 percent. At the same time, health care institutions were adopting pain as the fifth vital sign, and new mandatory pain-assessment and treatment standards were approved in 1999. The book connects the growth of opioid supply and the treatment of pain to the later emergency, rather than presenting the crisis as a sudden or purely individual misfortune.

The Declaration and Naloxone Order

Levine’s announcement combined two kinds of response: it formally identified the crisis as a public health emergency and made a lifesaving intervention easier to obtain. Under the standing order, any Virginia resident could purchase naloxone, an opioid antagonist that can reverse an overdose. The policy addressed the moment when overdose threatened life, giving residents a way to act without first securing a patient-specific prescription.

The order belonged to a wider turn toward harm reduction: reducing the harms associated with drug use, including death, even when stopping drug use was not an immediate outcome. In Vancouver, officials had paired naloxone distribution with clean-needle exchange and supervised injection sites where nurses could respond to overdoses. Virginia’s standing order was a less extensive intervention, but shared the practical premise that people must survive before treatment or recovery can follow.

Treatment Gaps Around the Emergency

Making overdose reversal more accessible did not make continuing care readily available. Virginia had repeatedly rejected Medicaid expansion under the Affordable Care Act, forgoing federal funds and coverage for 400,000 low-income residents. By contrast, states that expanded Medicaid could use the program to pay for treatment, counseling, and addiction medications, extending coverage to people who were too poor for private insurance but did not qualify for Medicaid under earlier rules.

The consequences of Virginia’s limited coverage appeared in individual efforts to find care. Kristi Fernandez had already sent her son, Jesse Bolstridge, to a ten-week rehabilitation program in Jacksonville in 2013. Although he was insured through his mother, she still faced a $25,000 bill, and he was weaned off buprenorphine after three weeks. Later, she could not afford to send him immediately to another rehabilitation center or travel with him to secure a transfer. His treatment history showed how cost and discontinuity could complicate recovery even for a family that had already managed to arrange care.

For Tess Henry, medication-assisted treatment was available but expensive to maintain. Insurance covered 80 percent of her buprenorphine medication, yet her addiction doctor required $700 up front and charged $90 to $100 for each follow-up visit, sometimes four visits a month. Waiting lists and cash-only practices added further barriers. At the time, federal rules generally capped the number of patients a certified prescriber could treat at 100, a limit raised to 275 later that year. The emergency declaration expanded one route to immediate survival while these financial and capacity constraints continued to impede longer-term treatment.

Response and Continuing Significance

Community responses tried to bridge the gap between crisis and care. Roanoke’s Hope Initiative volunteers assembled a five-page spreadsheet listing 36 rehabilitation and aftercare providers across the southeastern United States, matching referrals to patients’ finances and available beds. At monthly sessions at the Bradley Free Clinic, people without outstanding warrants could meet trained volunteers to work through treatment options; social-service workers also helped eligible visitors apply for Medicaid. Some volunteers arranged outpatient medication-assisted treatment, although the group remained divided over its use.

The scale of need continued to overwhelm available services. By early 2017, fentanyl-overdose calls were coming in at twice the rate of the same period a year earlier. In a region of 300,000 people, emergency-room doctors were seeing overdoses every day, sometimes several severe opioid-involved cases at once. A later proposal led by researcher Warren Bickel sought to connect overdose patients directly from emergency departments to outpatient buprenorphine treatment, while Roanoke’s community services board had added medication-assisted treatment for only 21 patients, and Carilion Clinic still had a three-week wait for outpatient care.

The declaration and standing order therefore marked a consequential but bounded intervention. They recognized overdose as a public health emergency and made naloxone more obtainable across the state. The continuing shortage of treatment, the costs and waits faced by patients, and the economic conditions linked to the crisis showed why emergency recognition and overdose reversal, though essential, could not by themselves provide a path into sustained care.